19 patents currently held
6 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Jan 2034. from the record
Of the 6 now held by other companies, 4 name Illumina Inc. as their current owner, and 2 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Jan 2034
Next term end
4
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jan 2034 · Medium confidence
Also notable
Ends Jan 2034 · High confidence
Also notable
Ends Mar 2036 · High confidence
Also notable
Ends Nov 2039 · High confidence
Bioinformatics Systems, Apparatuses, and Methods Executed on an Integrated Circuit Processing Platform
US 9,014,989
The most cited patent in this portfolio, cited by 176 later US patents, top 5% of utility patents granted in 2015 in our data. Protection runs to 2034.
Dynamic Genome Reference Generation for Improved NGS Accuracy and Reproducibility
US 9,697,327
Cited by 43 later US patents, top 10% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2034. A terminal disclaimer caps this term to an earlier patent's.
Method and System for Genomic Visualization
US 9,940,266
Cited by 26 later US patents, top 25% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2036.
Method And System For A Reduced Computation Hidden Markov Model In Computational Biology Applications
US 11,210,597
Granted 2021. Computed term ends 2039.
Formerly held, still cited
Notable
Ends Dec 2035 · High confidence
Cited by 64 later US patents, top 5% of utility patents granted in 2019 in our data. Protection runs to 2035.
now held by Cardea Bio, Inc.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jun 12, 2027The maintenance fee for Bioinformatics Systems, Apparatuses, and Methods Executed on an Integrated Circuit Processing Platform (US 11,842,796) comes due Jun 12, 2027. Unpaid by Dec 13, 2027, it lapses early.
- 1 fee due Jul 12, 2027The maintenance fee for Bioinformatics Systems, Apparatuses, and Methods Executed on an Integrated Circuit Processing Platform (US 9,235,680) comes due Jul 12, 2027. Unpaid by Jan 12, 2028, it lapses early.
- 2 fees due Oct 14, 2027
- 1 fee due Nov 17, 2027The maintenance fee for Bioinformatics Systems, Apparatuses, And Methods Executed On An Integrated Circuit Processing Platform (US 9,342,652) comes due Nov 17, 2027. Unpaid by May 17, 2028, it lapses early.
Recent changes
- 1 term has ended since Aug 23, 2026
- Sep 4 US 10,068,183 Bioinformatics Systems, Apparatuses, and Methods Executed on a Quantum Processing Platform · lapsed on the fee record
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Bioinformatics Systems, Apparatuses, and Methods Executed on an Integrated Circuit Processing Platform | 16 in force | to Jun 2035 |
| Method And System For A Reduced Computation Hidden Markov Model In Computational Biology Applications | 1 in force | to Nov 2039 |
| Method and System for Genomic Visualization | 1 in force | to Mar 2036 |
| Dynamic Genome Reference Generation for Improved NGS Accuracy and Reproducibility | 1 in force | to Jan 2034 |
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,014,989 | Bioinformatics Systems, Apparatuses, and Methods Executed on an Integrated Circuit Processing Platform In force · Medium confidence | In force | Medium confidence | |
| US 9,342,652 | Bioinformatics Systems, Apparatuses, And Methods Executed On An Integrated Circuit Processing Platform In force · Medium confidence | In force | Medium confidence | |
| US 9,697,327 | Dynamic Genome Reference Generation for Improved NGS Accuracy and Reproducibility In force · High confidence | In force | High confidence | |
| US 9,953,135 | Bioinformatics Systems, Apparatuses, and Methods Executed on an Integrated Circuit Processing Platform In force · Medium confidence | In force | Medium confidence | |
| US 10,049,179 | Bioinformatics Systems, Apparatuses, and Methods for Performing Secondary And/Or Tertiary Processing In force · Low confidence | In force | Low confidence | |
| US 10,068,052 | Bioinformatics Systems, Apparatuses, and Methods for Generating a De Bruijn Graph In force · Medium confidence | In force | Medium confidence | |
| US 10,210,308 | Bioinformatics Systems, Apparatuses, and Methods Executed on an Integrated Circuit Processing Platform In force · Medium confidence | In force | Medium confidence | |
| US 10,262,105 | Bioinformatics Systems, Apparatuses, and Methods Executed on an Integrated Circuit Processing Platform In force · Medium confidence | In force | Medium confidence | |
| US 10,622,096 | Bioinformatics Systems, Apparatuses, and Methods Executed on an Integrated Circuit Processing Platform In force · Medium confidence | In force | Medium confidence | |
| US 10,622,097 | Bioinformatics Systems, Apparatuses, and Methods Executed on an Integrated Circuit Processing Platform In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 19: 6 patents in force now held by others · 3 patents ended · 1 application pending · 6 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.